Skip to main content
. 2022 Jul 25;12(3):2378–2388. doi: 10.1002/cam4.5061

TABLE 2.

Duration of therapy for the unadjusted full population (N = 191)

All patients (N = 191) Cohort 1 (N = 40) Cohort 2 (N = 74) Cohort 3 (N = 22) Cohort 4 (N = 55)
Events, n (%) a 168 (88.0) 37 (92.5) 67 (90.5) 17 (77.3) 47 (85.5)
Median (95% CI), months 10.3 (9.4–10.7) 10.2 (5.3–10.8) 10.0 (7.6–11.0) 8.3 (5.2–10.6) 10.7 (9.8–11.3)

Abbreviation: CI, confidence interval.

a

Events were defined as patients switching to another systemic therapy or stopping treatment without reinitiating treatment. Censoring was performed if treatment was continued through the study end date.